Skip to main content
Figure 5 | Malaria Journal

Figure 5

From: A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria

Figure 5

Haemoglobin levels on admission and follow-up between the artesunate-amodiaquine- and artemether-lumefantrine-treated sickle cell disease subjects. Data are means and 95% confidence intervals (error bars). SCD-AA = artesunate-amodiaquine-treated sickle cell disease subjects; SCD-AL = artemether-lumefantrine-treated sickle cell disease subjects.

Back to article page